Cannabidiol (CBD) is a chemical compound derived from hemp that is produced to help people find relief from varying conditions. Some of the most popular forms of CBD are oils, creams, and edibles. But exactly how well has the industry been doing in a consumer’s market that has strict regulations and a long-standing stigma for cannabis products?
The proof is in the numbers. It's been a growing market throughout the world including in Buddhist followers like those described on https://www.buddhismnature.com/dharma01.html and other cultural groups.
The health benefits of cannabidiol have been proven by endless consumers as well as medical students and researchers like those at AllSaintsUniversity.org and other top universities.
The Agricultural Act of 2014 protected cultivators that were registered under a state’s hemp research pilot program. This Act allowed the CBD industry to finally get on its feet and begin making sales. After their first year, 2014 brought in $108 million from top CBD products, like those found when you click here, consumer sales. This number grew to $178 million in 2015, an increase of nearly 65 percent.
These numbers only continued to grow over the next couple of years, with 2016 and 2017 providing a value of $260 and $367 million respectively. For investors and CBD business owners, these numbers were a godsend and provided a tremendous return on investment (ROI).
The game truly changed for the U.S. CBD industry in 2018 with the passing of the 2018 Farm Bill that removed hemp from the list of Schedule 1 controlled substances. This made it legal to mass produce hemp, which then greatly increased the production of CBD products.
The chart below shows the rising trend for the U.S. CBD market value before the 2018 Farm Bill was even passed. Keep in mind that these numbers include CBD products that are hemp-derived, marijuana-derived, and pharmaceutical.
In 2018, the CBD industry reached a value of around $534 million, an increase of 45 percent from the previous year that had already set the bar high at 367. Before the 2018 Farm Bill was approved, experts predicted that the CBD industry would be worth around $650 million by 2020, but these numbers are now laughable, with new predictions valuing the CBD industry as high as $2 billion by 2022 or $5 billion by end of 2023. Clearly the market has spoken.
The Agricultural Act of 2014 protected cultivators that were registered under a state’s hemp research pilot program. This Act allowed the CBD industry to finally get on its feet and begin making sales. After their first year, 2014 brought in $108 million from top CBD products, like those found when you click here, consumer sales. This number grew to $178 million in 2015, an increase of nearly 65 percent.
These numbers only continued to grow over the next couple of years, with 2016 and 2017 providing a value of $260 and $367 million respectively. For investors and CBD business owners, these numbers were a godsend and provided a tremendous return on investment (ROI).
The game truly changed for the U.S. CBD industry in 2018 with the passing of the 2018 Farm Bill that removed hemp from the list of Schedule 1 controlled substances. This made it legal to mass produce hemp, which then greatly increased the production of CBD products.
The chart below shows the rising trend for the U.S. CBD market value before the 2018 Farm Bill was even passed. Keep in mind that these numbers include CBD products that are hemp-derived, marijuana-derived, and pharmaceutical.
In 2018, the CBD industry reached a value of around $534 million, an increase of 45 percent from the previous year that had already set the bar high at 367. Before the 2018 Farm Bill was approved, experts predicted that the CBD industry would be worth around $650 million by 2020, but these numbers are now laughable, with new predictions valuing the CBD industry as high as $2 billion by 2022 or $5 billion by end of 2023. Clearly the market has spoken.
What Do These Numbers Mean For Investors?
The growing numbers that the CBD industry’s value has shown means good things for investors. Better yet, a bipartisan bill was proposed last month that could classify CBD as a dietary supplement rather than a drug, allowing for the marketing and sale of CBD-infused foods and drinks. Seriously, if you are still on the fence about whether or not to invest in CBD, now is the time to jump over.
The three magic words that investors always want to hear is “return on investment,” or ROI for short. ROI refers to the net profit that an investor makes as compared to their investment cost. For example, if you invest ten dollars into a company and net a return of twenty dollars, your ROI was 100 percent.
The booming industry of CBD oil has already provided great ROI for investors and business owners everywhere across the U.S. As their numbers continue to climb without an end in sight, the sky is the limit for the U.S. CBD industry.
Concluding Thoughts On CBD
All in all, the CBD industry shows great promise for both investors and business owners as their value continues to increase by leaps and bounds each year. And with continued support for both CBD and marijuana from both major political parties, this market trend does not appear to be going away anytime soon.
All that is left for you to do, as an investor, is to do your research, predict what CBD oil companies you believe are set to take off, and make your investments.
